A study testing a new eye drop for dry eye
Part of Eyes & vision clinical trials.
This trial tests a new eye drop called RCI001 to see if it works better than a placebo for people with dry eye. You may be able to join if you have had dry eye for at least 6 months and have certain signs of dry eye during exams.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have had dry eye symptoms for at least 6 months and have used or wanted to use eye drops for it in the last 6 months.
- You have a certain level of dry eye signs during eye exams, like low tear production and staining of the eye surface.
- You are not pregnant, nursing, or planning pregnancy, and you agree to use birth control if needed.
- You have not used certain dry eye prescription drops in the last 45 days.
- You can stop using other eye drops (including artificial tears) for 72 hours before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This study tests different doses of an investigational eye drop (BRM421) to see if it safely helps people with dry eye disease. It may be an option if you have had dry eyes for a while and are looking for a new treatment.
This study tests a new eye drop formula to see if it safely improves dry eye symptoms. It may be a good option if you have been diagnosed with dry eye and have limited tear production.
This study tests an eye drop called lifitegrast for people with dry eye disease. It looks at whether the drops can improve eye comfort, reduce dryness, and help eye surface health. You may be able to join if you have had dry eye symptoms and used artificial tears in the past month.
This trial tests different doses of a new eye drop (HUC1-394) to see which dose works best for people with moderate to severe dry eye disease. You may qualify if your dry eye symptoms have lasted at least 3 months and you have low tear production along with other signs of dry eye.
This study tests two types of preservative-free eye drops to see which is more effective for people with mild to moderate dry eye disease. You will use one of the drops as directed, and the study will monitor your symptoms and eye health over time.
Hear when a new Dry Eye Disease (DED) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.